[Agranulocytosis and cholestatic hepatitis during treatment with ajmaline].
D000380:Agranulocytosis / Q000139:chemically induced*; D000404:Ajmaline / Q000009:adverse effects* / Q000627:therapeutic use; D002779:Cholestasis / Q000139:chemically induced* / Q000150:complications; D005260:Female; D006801:Humans; D008875:Middle Aged
D000404:Ajmaline
Agranulocytose et hépatite cholestatique au cours d'un traitement par l'ajmaline